Drug Safety and Pharmacovigilance

Drug safety relates to the potential for adverse effects related to the administration of drugs. Efforts to establish the safely profile of drugs begin early in their development, with in vitro and in vivo toxicity testing, and continue through clinical trials leading up to drug approval and following approval in specific post-marketing studies or general pharmacovigilance efforts. Pharmacovigilance (PV or PhV), also known as drug safety, is the pharmacological science relating to the collection, detection, assessment, monitoring, and prevention of adverse effects with pharmaceutical products.The etymological roots for the word "pharmacovigilance" are: pharmakon (Greek for drug) and vigilare (Latin for to keep watch). As such, pharmacovigilance heavily focuses on adverse drug reactions, or ADRs, which are defined as any response to a drug which is noxious and unintended, including lack of efficacy (the condition that this definition only applies with the doses normally used for the prophylaxis, diagnosis or therapy of disease, or for the modification of physiological disorder function was excluded with the latest amendment of the applicable legislation). Medication errors such as overdose, and misuse and abuse of a drug as well as drug exposure during pregnancy and breastfeeding, are also of interest, even without an adverse event, because they may result in an adverse drug reaction Signal Detection in Drug Safety

 

     

     

      Related Conference of Drug Safety and Pharmacovigilance

      August 18-19, 2025

      40th World Congress on Pharmacology and Therapeutics

      Valencia, Spain
      August 27-28, 2025

      20th World Congress on Drug Formulation & Drug Delivery

      Amsterdam, Netherlands
      September 19-20, 2025

      18th World Drug Delivery Summit

      Paris, France
      September 22-23, 2025

      Pharma Biotech Expo

      Toronto, Canada
      September 23-24, 2025

      10th International Conference on Future Pharma and Innovations

      Amsterdam, Netherlands
      September 24-25, 2025

      5th World Congress on Rare Diseases & Orphan Drugs

      Aix-en-Provence, France
      October 23-24, 2025

      21st Annual Meet on Pharmaceutical Sciences

      Aix-en-Provence, France
      November 11-12, 2025

      6th Annual Congress on Antibiotics and Bacterial Infections

      Amsterdam, Netherlands
      November 13-14, 2025

      21st International Conference on Pharmaceutical Chemistry

      Aix-en-Provence, France
      November 20-21, 2025

      21st Annual Congress on Pharmacology and Toxicology

      Paris, France
      November 27-28, 2025

      4th World Congress on Precision and Personalized Medicine

      Zurich, Switzerland
      November 27-28, 2025

      4th World Conference on Pharma Industry and Medical Devices

      Zurich, Switzerland
      November 27-28, 2025

      13th International Conference on Clinical Trials

      Amsterdam, Netherlands
      February 23-24, 2026

      3rd World Congress on Biologics and Biosimilars

      London, Aland Islands
      April 27-28, 2026

      9th European Biopharma Congress

      Paris, Aland Islands

      Drug Safety and Pharmacovigilance Conference Speakers

        Recommended Sessions

        Related Journals

        Are you interested in